Literature DB >> 6606314

NMR imaging of the abdomen at 0.12 T: initial clinical experience with a resistive magnet.

H Y Kressel, L Axel, D Thickman, A Alavi, H Pollack, P Arger, W Edelstein, P Bottomley, R Redington, S Baum.   

Abstract

Forty-five patients with a variety of abdominal abnormalities and five normal volunteers were imaged on a 0.12 T resistive nuclear magnetic resonance system. Scans were obtained with saturation-recovery technique and short repetition times. The images reflected both proton density and T1 information. A variety of neoplastic and nonneoplastic disease processes involving the abdomen were imaged. Results suggest that clinically useful images clearly may be obtained at 0.12 T. In addition, saturation-recovery imaging with short repetition rates can detect a wide range of abdominal abnormalities.

Entities:  

Mesh:

Year:  1983        PMID: 6606314     DOI: 10.2214/ajr.141.6.1179

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Magnetic resonance imaging of the kidneys.

Authors:  J H Newhouse; J A Markisz; E Kazam
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

2.  Inherent contrast in magnetic resonance imaging and the potential for contrast enhancement. The 1984 L. Henry Garland lecture.

Authors:  R C Brasch
Journal:  West J Med       Date:  1985-06

3.  Ultrasound, CT, and MRI comparison in primary and secondary tumors of the liver.

Authors:  W L Curati; A Halevy; R N Gibson; D H Carr; L H Blumgart; R E Steiner
Journal:  Gastrointest Radiol       Date:  1988

Review 4.  Prenatal diagnosis and management of bilateral hydronephrosis.

Authors:  T M Crombleholme; M R Harrison; M T Longaker; J C Langer
Journal:  Pediatr Nephrol       Date:  1988-07       Impact factor: 3.714

5.  Magnetic resonance imaging of avascular necrosis of the femoral head.

Authors:  D Thickman; L Axel; H Y Kressel; M Steinberg; H Chen; M Velchick; M Fallon; M Dalinka
Journal:  Skeletal Radiol       Date:  1986       Impact factor: 2.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.